BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 216 hits of Enz. Inhib. data with enzyme = 'Cytochrome P450 11B1, mitochondrial' and Substrate = 'to-be-curated'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286224
PNG
(4-(6-fluoro-3-ethylimidazo[1,2- a]pyridin-2-yl)iso...)
Show SMILES Cc1c(nc2ccc(F)cn12)-c1cncc2ccccc12
Show InChI InChI=1S/C17H12FN3/c1-11-17(20-16-7-6-13(18)10-21(11)16)15-9-19-8-12-4-2-3-5-14(12)15/h2-10H,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 14.8n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286221
PNG
(6-fluoro-3-methyl-2-(5- methoxypyridin-3- yl)imida...)
Show SMILES COc1cncc(c1)-c1nc2ccc(F)cn2c1C
Show InChI InChI=1S/C14H12FN3O/c1-9-14(10-5-12(19-2)7-16-6-10)17-13-4-3-11(15)8-18(9)13/h3-8H,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 32.4n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286222
PNG
(6-fluoro-3-methyl-2-(5- methylpyridin-3-yl)imidazo...)
Show SMILES Cc1c(nc2ccc(F)cn12)-c1cncc(C)c1
Show InChI InChI=1S/C14H12FN3/c1-9-5-11(7-16-6-9)14-10(2)18-8-12(15)3-4-13(18)17-14/h3-8H,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 40.7n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM50206963
PNG
(CHEMBL3948337 | US9518055, Example 41)
Show SMILES Fc1ccc2nc(c(C3CC3)n2c1)-c1cncc2ccccc12
Show InChI InChI=1S/C19H14FN3/c20-14-7-8-17-22-18(19(12-5-6-12)23(17)11-14)16-10-21-9-13-3-1-2-4-15(13)16/h1-4,7-12H,5-6H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 57.5n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286214
PNG
(6-fluoro-2-(5-methylpyridin-3- yl)imidazo[1,2-a]py...)
Show SMILES Cc1cncc(c1)-c1cn2cc(F)ccc2n1
Show InChI InChI=1S/C13H10FN3/c1-9-4-10(6-15-5-9)12-8-17-7-11(14)2-3-13(17)16-12/h2-8H,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 60n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286211
PNG
(6-fluoro-2-(4-methylpyridin-3- yl)imidazo[1,2-a]py...)
Show SMILES Cc1ccncc1-c1cn2cc(F)ccc2n1
Show InChI InChI=1S/C13H10FN3/c1-9-4-5-15-6-11(9)12-8-17-7-10(14)2-3-13(17)16-12/h2-8H,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 63n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM50206961
PNG
(CHEMBL3893614 | US9518055, Example 31)
Show SMILES Fc1ccc2nc(c(C3CC3)n2c1)-c1cncc(F)c1
Show InChI InChI=1S/C15H11F2N3/c16-11-3-4-13-19-14(10-5-12(17)7-18-6-10)15(9-1-2-9)20(13)8-11/h3-9H,1-2H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 67n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286219
PNG
(7-methyl-2-(6-methylpyridin-3- yl)-3-methylimidazo...)
Show SMILES Cc1c(nc2cc(C)ccn12)-c1cnccc1C
Show InChI InChI=1S/C15H15N3/c1-10-5-7-18-12(3)15(17-14(18)8-10)13-9-16-6-4-11(13)2/h4-9H,1-3H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 68n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286226
PNG
(3-cyclopropyl-6-fluoro-2- (pyridin-3-yl)imidazo[1,...)
Show SMILES Fc1ccc2nc(c(C3CC3)n2c1)-c1cccnc1
Show InChI InChI=1S/C15H12FN3/c16-12-5-6-13-18-14(11-2-1-7-17-8-11)15(10-3-4-10)19(13)9-12/h1-2,5-10H,3-4H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 76n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287739
PNG
(US10085984, Example 117)
Show SMILES Fc1cc2nc(-c3cnnc(OCC4CC4)c3)n(C3CC3)c2cc1F
Show InChI InChI=1S/C18H16F2N4O/c19-13-6-15-16(7-14(13)20)24(12-3-4-12)18(22-15)11-5-17(23-21-8-11)25-9-10-1-2-10/h5-8,10,12H,1-4,9H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287661
PNG
(US10085984, Example 39)
Show SMILES CC(C)(C)OC(=O)N1CCN(CC1)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C23H26F2N6O2/c1-23(2,3)33-22(32)30-8-6-29(7-9-30)20-10-14(13-26-28-20)21-27-18-11-16(24)17(25)12-19(18)31(21)15-4-5-15/h10-13,15H,4-9H2,1-3H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287719
PNG
(US10085984, Example 97)
Show SMILES CCCCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C18H18F2N4/c1-2-3-4-12-7-11(10-21-23-12)18-22-16-8-14(19)15(20)9-17(16)24(18)13-5-6-13/h7-10,13H,2-6H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287709
PNG
(US10085984, Example 87)
Show SMILES N#Cc1ccc2nc(-c3cnnc(c3)C3CC3)n(C3CC3)c2n1
Show InChI InChI=1S/C17H14N6/c18-8-12-3-6-14-17(20-12)23(13-4-5-13)16(21-14)11-7-15(10-1-2-10)22-19-9-11/h3,6-7,9-10,13H,1-2,4-5H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286223
PNG
(6-fluoro-3-methyl-2-(4- methylpyridin-3-yl)imidazo...)
Show SMILES Cc1c(nc2ccc(F)cn12)-c1cnccc1C
Show InChI InChI=1S/C14H12FN3/c1-9-5-6-16-7-12(9)14-10(2)18-8-11(15)3-4-13(18)17-14/h3-8H,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 135n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287681
PNG
(US10085984, Example 59)
Show SMILES Fc1cc2nc(-c3cnnc(c3)C3CC3)n(C3CC3)c2cc1F
Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(11-3-4-11)17(21-15)10-5-14(9-1-2-9)22-20-8-10/h5-9,11H,1-4H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287692
PNG
(US10085984, Example 70)
Show SMILES CC(F)(F)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C16H12F4N4/c1-16(19,20)14-4-8(7-21-23-14)15-22-12-5-10(17)11(18)6-13(12)24(15)9-2-3-9/h4-7,9H,2-3H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287694
PNG
(US10085984, Example 72)
Show SMILES CCn1c(nc2cc(F)c(F)cc12)-c1cnnc(c1)C1CC1
Show InChI InChI=1S/C16H14F2N4/c1-2-22-15-7-12(18)11(17)6-14(15)20-16(22)10-5-13(9-3-4-9)21-19-8-10/h5-9H,2-4H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287697
PNG
(US10085984, Example 75)
Show SMILES N#Cc1ccc2nc(-c3cnnc(c3)C3CC3)n(C3CC3)c2c1
Show InChI InChI=1S/C18H15N5/c19-9-11-1-6-15-17(7-11)23(14-4-5-14)18(21-15)13-8-16(12-2-3-12)22-20-10-13/h1,6-8,10,12,14H,2-5H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287703
PNG
(US10085984, Example 81)
Show SMILES CCS(=O)(=O)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C16H14F2N4O2S/c1-2-25(23,24)15-5-9(8-19-21-15)16-20-13-6-11(17)12(18)7-14(13)22(16)10-3-4-10/h5-8,10H,2-4H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287706
PNG
(US10085984, Example 84)
Show SMILES Clc1ccc2nc(-c3cnnc(c3)C3CC3)n(C3CC3)c2c1
Show InChI InChI=1S/C17H15ClN4/c18-12-3-6-14-16(8-12)22(13-4-5-13)17(20-14)11-7-15(10-1-2-10)21-19-9-11/h3,6-10,13H,1-2,4-5H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287710
PNG
(US10085984, Example 88)
Show SMILES Fc1cc2nc(-c3cnnc(CN4CCCS4(=O)=O)c3)n(C3CC3)c2cc1F
Show InChI InChI=1S/C18H17F2N5O2S/c19-14-7-16-17(8-15(14)20)25(13-2-3-13)18(22-16)11-6-12(23-21-9-11)10-24-4-1-5-28(24,26)27/h6-9,13H,1-5,10H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287713
PNG
(US10085984, Example 91)
Show SMILES CC(NS(C)(=O)=O)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C17H17F2N5O2S/c1-9(23-27(2,25)26)14-5-10(8-20-22-14)17-21-15-6-12(18)13(19)7-16(15)24(17)11-3-4-11/h5-9,11,23H,3-4H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287679
PNG
(US10085984, Example 57)
Show SMILES CC(F)(F)COc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C17H14F4N4O/c1-17(20,21)8-26-15-4-9(7-22-24-15)16-23-13-5-11(18)12(19)6-14(13)25(16)10-2-3-10/h4-7,10H,2-3,8H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287673
PNG
(US10085984, Example 51)
Show SMILES CC(C)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C17H16F2N4/c1-9(2)14-5-10(8-20-22-14)17-21-15-6-12(18)13(19)7-16(15)23(17)11-3-4-11/h5-9,11H,3-4H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287671
PNG
(US10085984, Example 49)
Show SMILES Fc1ccc(cc1)-c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C20H13F3N4/c21-13-3-1-11(2-4-13)17-7-12(10-24-26-17)20-25-18-8-15(22)16(23)9-19(18)27(20)14-5-6-14/h1-4,7-10,14H,5-6H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287666
PNG
(US10085984, Example 44)
Show SMILES Fc1cc2nc(-c3cnnc(c3)N3CCC(F)(F)CC3)n(C3CC3)c2cc1F
Show InChI InChI=1S/C19H17F4N5/c20-13-8-15-16(9-14(13)21)28(12-1-2-12)18(25-15)11-7-17(26-24-10-11)27-5-3-19(22,23)4-6-27/h7-10,12H,1-6H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287660
PNG
(US10085984, Example 38)
Show SMILES CS(=O)(=O)N1CCN(CC1)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C19H20F2N6O2S/c1-30(28,29)26-6-4-25(5-7-26)18-8-12(11-22-24-18)19-23-16-9-14(20)15(21)10-17(16)27(19)13-2-3-13/h8-11,13H,2-7H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287746
PNG
(US10085984, Example 124)
Show SMILES CC(C)Sc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C17H16F2N4S/c1-9(2)24-16-5-10(8-20-22-16)17-21-14-6-12(18)13(19)7-15(14)23(17)11-3-4-11/h5-9,11H,3-4H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287652
PNG
(US10085984, Example 30)
Show SMILES Cc1cc(cnn1)-c1cc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C16H14FN3/c1-10-6-12(9-18-19-10)15-7-11-2-3-13(17)8-16(11)20(15)14-4-5-14/h2-3,6-9,14H,4-5H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287651
PNG
(US10085984, Example 29)
Show SMILES COc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N
Show InChI InChI=1S/C16H13N5O/c1-22-15-7-11(9-18-20-15)16-19-13-5-2-10(8-17)6-14(13)21(16)12-3-4-12/h2,5-7,9,12H,3-4H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287648
PNG
(US10085984, Example 26)
Show SMILES CCn1c(nc2ccc(F)cc12)-c1cnnc(C)c1
Show InChI InChI=1S/C14H13FN4/c1-3-19-13-7-11(15)4-5-12(13)17-14(19)10-6-9(2)18-16-8-10/h4-8H,3H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287647
PNG
(US10085984, Example 25)
Show SMILES CN(C)c1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C16H15F2N5/c1-22(2)15-5-9(8-19-21-15)16-20-13-6-11(17)12(18)7-14(13)23(16)10-3-4-10/h5-8,10H,3-4H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287645
PNG
(US10085984, Example 23)
Show SMILES COc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C15H12F2N4O/c1-22-14-4-8(7-18-20-14)15-19-12-5-10(16)11(17)6-13(12)21(15)9-2-3-9/h4-7,9H,2-3H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287636
PNG
(US10085984, Example 14)
Show SMILES Fc1ccc2nc(-c3cnnc4ccccc34)n(C3CC3)c2c1
Show InChI InChI=1S/C18H13FN4/c19-11-5-8-16-17(9-11)23(12-6-7-12)18(21-16)14-10-20-22-15-4-2-1-3-13(14)15/h1-5,8-10,12H,6-7H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287633
PNG
(US10085984, Example 11)
Show SMILES Fc1ccc(cc1)N1CCN(CC1)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C24H22F2N6/c25-17-1-4-19(5-2-17)30-9-11-31(12-10-30)23-13-16(15-27-29-23)24-28-21-8-3-18(26)14-22(21)32(24)20-6-7-20/h1-5,8,13-15,20H,6-7,9-12H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287632
PNG
(US10085984, Example 10)
Show SMILES Fc1ccc2nc(-c3cnnc(c3)N3CCOCC3)n(C3CC3)c2c1
Show InChI InChI=1S/C18H18FN5O/c19-13-1-4-15-16(10-13)24(14-2-3-14)18(21-15)12-9-17(22-20-11-12)23-5-7-25-8-6-23/h1,4,9-11,14H,2-3,5-8H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287655
PNG
(US10085984, Example 33)
Show SMILES CCc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C16H14F2N4/c1-2-10-5-9(8-19-21-10)16-20-14-6-12(17)13(18)7-15(14)22(16)11-3-4-11/h5-8,11H,2-4H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287740
PNG
(US10085984, Example 118)
Show SMILES FC(F)(F)COc1cc(cnn1)-c1nc2ccc(cc2n1C1CC1)C#N
Show InChI InChI=1S/C17H12F3N5O/c18-17(19,20)9-26-15-6-11(8-22-24-15)16-23-13-4-1-10(7-21)5-14(13)25(16)12-2-3-12/h1,4-6,8,12H,2-3,9H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287728
PNG
(US10085984, Example 106)
Show SMILES Fc1cc2nc(-c3cnnc4CCCCc34)n(C3CC3)c2cc1F
Show InChI InChI=1S/C18H16F2N4/c19-13-7-16-17(8-14(13)20)24(10-5-6-10)18(22-16)12-9-21-23-15-4-2-1-3-11(12)15/h7-10H,1-6H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 300n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM50206972
PNG
(CHEMBL3911595 | US9518055, Example 29)
Show SMILES Cc1cncc(c1)-c1nc2ccc(F)cn2c1C1CC1
Show InChI InChI=1S/C16H14FN3/c1-10-6-12(8-18-7-10)15-16(11-2-3-11)20-9-13(17)4-5-14(20)19-15/h4-9,11H,2-3H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Patents

US Patent
n/an/a 589n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM286218
PNG
(8-methyl-2-(6-methylpyridin-3- yl)-3-methylimidazo...)
Show SMILES Cc1c(nc2c(C)cccn12)-c1cnccc1C
Show InChI InChI=1S/C15H15N3/c1-10-6-7-16-9-13(10)14-12(3)18-8-4-5-11(2)15(18)17-14/h4-9H,1-3H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 646n/an/an/an/an/an/a



Merck Sharp & Dohme

US Patent


Assay Description
V79 cell lines stably expressing the either the human CYP11B2 or the human CYP11B1 enzyme were generated using a standard transfection protocol. V79 ...


US Patent US9518055 (2016)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287625
PNG
(US10085984, Example 3)
Show SMILES Fc1ccc2nc(-c3cnnc(Cl)c3)n(C3CC3)c2c1
Show InChI InChI=1S/C14H10ClFN4/c15-13-5-8(7-17-19-13)14-18-11-4-1-9(16)6-12(11)20(14)10-2-3-10/h1,4-7,10H,2-3H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287626
PNG
(US10085984, Example 4)
Show SMILES Fc1ccc2nc(-c3cnnc(C=C)c3)n(C3CC3)c2c1
Show InChI InChI=1S/C16H13FN4/c1-2-12-7-10(9-18-20-12)16-19-14-6-3-11(17)8-15(14)21(16)13-4-5-13/h2-3,6-9,13H,1,4-5H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287628
PNG
(US10085984, Example 6)
Show SMILES CCc1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C16H15FN4/c1-2-12-7-10(9-18-20-12)16-19-14-6-3-11(17)8-15(14)21(16)13-4-5-13/h3,6-9,13H,2,4-5H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287629
PNG
(US10085984, Example 7)
Show SMILES OC(c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1)C(F)(F)F
Show InChI InChI=1S/C16H12F4N4O/c17-9-1-4-11-13(6-9)24(10-2-3-10)15(22-11)8-5-12(23-21-7-8)14(25)16(18,19)20/h1,4-7,10,14,25H,2-3H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287634
PNG
(US10085984, Example 12)
Show SMILES CC(C)(O)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C17H17FN4O/c1-17(2,23)15-7-10(9-19-21-15)16-20-13-6-3-11(18)8-14(13)22(16)12-4-5-12/h3,6-9,12,23H,4-5H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287637
PNG
(US10085984, Example 15)
Show SMILES Cc1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C15H13FN4/c1-9-6-10(8-17-19-9)15-18-13-5-2-11(16)7-14(13)20(15)12-3-4-12/h2,5-8,12H,3-4H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287640
PNG
(US10085984, Example 18)
Show SMILES CC(C)NC(=O)CN1CCN(CC1)c1cc(cnn1)-c1nc2ccc(F)cc2n1C1CC1
Show InChI InChI=1S/C23H28FN7O/c1-15(2)26-22(32)14-29-7-9-30(10-8-29)21-11-16(13-25-28-21)23-27-19-6-3-17(24)12-20(19)31(23)18-4-5-18/h3,6,11-13,15,18H,4-5,7-10,14H2,1-2H3,(H,26,32)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287641
PNG
(US10085984, Example 19)
Show SMILES Cc1cc(cnn1)-c1nc2cc(F)c(F)cc2n1C1CC1
Show InChI InChI=1S/C15H12F2N4/c1-8-4-9(7-18-20-8)15-19-13-5-11(16)12(17)6-14(13)21(15)10-2-3-10/h4-7,10H,2-3H2,1H3
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial


(Homo sapiens (human))
BDBM287642
PNG
(US10085984, Example 20)
Show SMILES Fc1ccc2nc(-c3cnnc(c3)N3CCN(CC(=O)N4CCCC4)CC3)n(C3CC3)c2c1
Show InChI InChI=1S/C24H28FN7O/c25-18-3-6-20-21(14-18)32(19-4-5-19)24(27-20)17-13-22(28-26-15-17)30-11-9-29(10-12-30)16-23(33)31-7-1-2-8-31/h3,6,13-15,19H,1-2,4-5,7-12,16H2
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 750n/an/an/an/an/an/a



Viamet Pharmaceuticals (Bermuda), Ltd.

US Patent


Assay Description
V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...


US Patent US10085984 (2018)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 216 total )  |  Next  |  Last  >>
Jump to: